Deals of the day-Mergers and acquisitions

TS Financial Holding Co

01/06/2021 12:00

June 1 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1100 GMT on Tuesday:

    ** Private-equity firms KKR & Co  KKR.N  and Clayton
Dubilier & Rice LLC (CD&R) are nearing a deal to take Cloudera
Inc  CLDR.N  private at a valuation of $4.7 billion, Bloomberg
News reported on Monday, citing a person familiar with the
matter.  urn:newsml:reuters.com:*:nL3N2NJ0WM
    
    ** Dye & Durham Ltd  DND.TO , a Canadian cloud-based
software maker, has received a buyout offer from a
management-led shareholder group worth about C$3.4 billion ($2.8
billion), less than a year after its flotation on the Toronto
Stock Exchange.  urn:newsml:reuters.com:*:nL2N2NI1I2
    
    ** Novartis  NOVN.S  has signed a collaboration agreement
and option to acquire Cellerys, a Zurich-based startup
conducting research on a therapy to fight multiple sclerosis,
the Swiss drugmaker said on Tuesday.  urn:newsml:reuters.com:*:nFWN2NI0DK
    
    ** Taiwan has given conditional approval for Taishin
Financial Holding Co's  2887.TW  purchase of Prudential
Financial Inc's  PRU.N  Taiwan unit, which it agreed to buy last
year for T$5.5 billion ($199.41 million).  urn:newsml:reuters.com:*:nL2N2NJ0L1
    
    ** A consortium led by private-equity firm KKR  KKR.N  and
investment firm TIGA Investments will buy office space provider
The Executive Centre (TEC), the companies said on Tuesday.
 urn:newsml:reuters.com:*:nL2N2NJ0I2
    
    ** German commercial real estate firm Summit Properties Ltd
said on Tuesday it had sold a portion of its German portfolio to
an international fund for 1 billion euros ($1.22 billion).
 urn:newsml:reuters.com:*:nL3N2NJ1NZ
    
    ** Digital freight startup Sennder on Tuesday said it had
raised a further $80 million from investors to expand its
business, having decided against going public via a merger with
a listed blank-cheque company.  urn:newsml:reuters.com:*:nL5N2NF4DW
    
    ** EU antitrust regulators will decide by July 5 whether to
clear Anglo-Swedish drugmaker AstraZeneca's  AZN.L  $39 billion
bid for U.S.-based Alexion  ALXN.O , a European Commission
filing showed on Tuesday.  urn:newsml:reuters.com:*:nL2N2NJ0J6

 (Compiled by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com;))